A movable unshielded magnetocardiography system

Motion artifact variability in biomagnetic wearable devices

Motion artifacts can be a significant noise source in biomagnetic measurements when magnetic sensors are not separated from the signal source. In ambient environments, motion artifacts can be up to ten times stronger than the desired signals, varying with environmental conditions. This study evaluates the variability of these artifacts and the effectiveness of a gradiometer in reducing them in such settings. To achieve these objectives, we first measured the single channel output in varying magnetic field conditions to observe the effect of homogeneous and gradient background fields. Our analysis revealed that the variability in motion artifact within an ambient environment is primarily influenced by the gradient magnetic field rather than the homogeneous one. Subsequently, we configured a gradiometer in parallel and vertical alignment with the direction of vibration (X-axis). Our findings indicated that in a gradient background magnetic field ranging from 1 nT/mm to 10 nT/mm, the single-channel sensor output exhibited a change of 164.97 pT per mm unit increase, while the gradiometer output showed a change of only 0.75 pT/mm within the same range. Upon repositioning the gradiometer vertically (Y direction), perpendicular to the direction of vibration, the single-channel output slope increased to 196.85 pT, whereas the gradiometer output only increased by 1.06 pT/mm for the same range. Our findings highlight the influence of ambient environments on motion artifacts and demonstrate the potential of gradiometers to mitigate these effects. In the future, we plan to record biomagnetic signals both inside and outside the shielded room to compare the efficacy of different gradiometer designs under varying environmental conditions.

Performance of a Radio-Frequency Two-Photon Atomic Magnetometer in Different Magnetic Induction Measurement Geometries

Measurements monitoring the inductive coupling between oscillating radio-frequency magnetic fields and objects of interest create versatile platforms for non-destructive testing. The benefits of ultra-low-frequency measurements, i.e., below 3 kHz, are sometimes outweighed by the fundamental and technical difficulties related to operating pick-up coils or other field sensors in this frequency range. Inductive measurements with the detection based on a two-photon interaction in rf atomic magnetometers address some of these issues as the sensor gains an uplift in its operational frequency. The developments reported here integrate the fundamental and applied aspects of the two-photon process in magnetic induction measurements. In this paper, all the spectral components of the two-photon process are identified, which result from the non-linear interactions between the rf fields and atoms. For the first time, a method for the retrieval of the two-photon phase information, which is critical for inductive measurements, is also demonstrated. Furthermore, a self-compensation configuration is introduced, whereby high-contrast measurements of defects can be obtained due to its insensitivity to the primary field, including using simplified instrumentation for this configuration by producing two rf fields with a single rf coil.

Picotesla-sensitivity microcavity optomechanical magnetometry

Cavity optomechanical systems have enabled precision sensing of magnetic fields, by leveraging the optical resonance-enhanced readout and mechanical resonance-enhanced response. Previous studies have successfully achieved mass-produced and reproducible microcavity optomechanical magnetometry (MCOM) by incorporating Terfenol-D thin films into high-quality (Q) factor whispering gallery mode (WGM) microcavities. However, the sensitivity was limited to 585 pT Hz-1/2, over 20 times inferior to those using Terfenol-D particles. In this work, we propose and demonstrate a high-sensitivity and mass-produced MCOM approach by sputtering a FeGaB thin film onto a high-Q SiO2 WGM microdisk. Theoretical studies are conducted to explore the magnetic actuation constant and noise-limited sensitivity by varying the parameters of the FeGaB film and SiO2 microdisk. Multiple magnetometers with different radii are fabricated and characterized. By utilizing a microdisk with a radius of 355 μm and a thickness of 1 μm, along with a FeGaB film with a radius of 330 μm and a thickness of 1.3 μm, we have achieved a remarkable peak sensitivity of 1.68 pT Hz-1/2 at 9.52 MHz. This represents a significant improvement of over two orders of magnitude compared with previous studies employing sputtered Terfenol-D film. Notably, the magnetometer operates without a bias magnetic field, thanks to the remarkable soft magnetic properties of the FeGaB film. Furthermore, as a proof of concept, we have demonstrated the real-time measurement of a pulsed magnetic field simulating the corona current in a high-voltage transmission line using our developed magnetometer. These high-sensitivity magnetometers hold great potential for various applications, such as magnetic induction tomography and corona current monitoring.

Bedside Magnetocardiography with a Scalar Sensor Array

Decades of research have shown that magnetocardiography (MCG) has the potential to improve cardiac care decisions. However, sensor and system limitations have prevented its widespread adoption in clinical practice. We report an MCG system built around an array of scalar, optically pumped magnetometers (OPMs) that effectively rejects ambient magnetic interference without magnetic shielding. We successfully used this system, in conjunction with custom hardware and noise rejection algorithms, to record magneto-cardiograms and functional magnetic field maps from 30 volunteers in a regular downtown office environment. This demonstrates the technical feasibility of deploying our device architecture at the point-of-care, a key step in making MCG usable in real-world settings.

Optimizing biomagnetic sensor performance through in silico diagnostics: A novel approach with BEST (Biomagnetism Evaluation via Simulated Testing)

Advancing biomagnetic measurement capabilities requires a nuanced understanding of sensor performance beyond traditional metrics. This study introduces Biomagnetism Evaluation via Simulated Testing (BEST), a novel methodology combining a current dipole model simulating cardiac biomagnetic fields with a convolutional neural network. Our investigation reveals that optimal sensor array performance is achieved when sensors are in close proximity to the magnetic source, with a shorter effective domain. Contrary to common assumptions, the bottom edge length of the sensor has a negligible impact on array performance. BEST provides a versatile framework for exploring the influence of diverse technical indicators on biomagnetic sensor performance, offering valuable insights for sensor development and selection.

An optically pumped magnetic gradiometer for the detection of human biomagnetism

We realise an intrinsic optically pumped magnetic gradiometer based on non-linear magneto-optical rotation. We show that our sensor can reach a gradiometric sensitivity of 18 fT cm - 1 Hz - 1 and can reject common mode homogeneous magnetic field noise with up to 30 dB attenuation. We demonstrate that our magnetic field gradiometer is sufficiently sensitive and resilient to be employed in biomagnetic applications. In particular, we are able to record the auditory evoked response of the human brain, and to perform real-time magnetocardiography in the presence of external magnetic field disturbances. Our gradiometer provides complementary capabilities in human biomagnetic sensing to optically pumped magnetometers, and opens new avenues in the detection of human biomagnetism.

The magnetocardiogram

The magnetic field produced by the heart's electrical activity is called the magnetocardiogram (MCG). The first 20 years of MCG research established most of the concepts, instrumentation, and computational algorithms in the field. Additional insights into fundamental mechanisms of biomagnetism were gained by studying isolated hearts or even isolated pieces of cardiac tissue. Much effort has gone into calculating the MCG using computer models, including solving the inverse problem of deducing the bioelectric sources from biomagnetic measurements. Recently, most magnetocardiographic research has focused on clinical applications, driven in part by new technologies to measure weak biomagnetic fields.

Capacitive Bionic Magnetic Sensors Based on One-Step Biointerface Preparation

Magnetic biomolecule-based bionic magnetic field sensors are anticipated to open up novel pathways for magnetic field detection. The detection range and accuracy of current bionic magnetic field sensors are limited, and little work is based on the capacitive response principle. We successfully developed a biochemical interface with an extralarge target-receptor size ratio, which can be manufactured in a single step for weak magnetic field detection across a wide frequency range, and we used electrochemical capacitance as a magnetic field change conduction strategy. The thickness-controllable nanoscale bovine serum albumin/graphene layer on an indium tin oxide working electrode combines with the one-step preparation method to immobilize the MagR/Cry4 complex. This capacitive bionic magnetic sensor can achieve the detection range of 0-120 mT. This biointerface design strategy obtains the further improvement of the performance of this bionic magnetic field sensor. Furthermore, the biointerface construction and optimization methodology in this proposal has potential applications in the design of other medical biosensors.

Recent Developments in Fabrication Methods and Measurement Schemes for Optically Pumped Magnetic Gradiometers: A Comprehensive Review

Optically pumped gradiometers have long been utilized in measurement in the International Geomagnetic Reference Field (IGRF). With advancements in technologies such as laser diodes and microfabrication, integrated gradiometers with compact sizes have become available, enabling improvements in magnetoencephalography and fetal magnetocardiography within shielded spaces. Moreover, there is a growing interest in the potential of achieving biomagnetic source detection without shielding. This review focuses on recent developments in optically pumped magnetic field gradiometers, including various fabrication methods and measurement schemes. The strengths and weaknesses of different types of optically pumped gradiometers are also analyzed.

Light-narrowed parametric resonance magnetometer with the fundamental sensitivity beyond the spin-exchange limit

In the field of biomagnetic measurements, one of the most important recent challenges is to perform measurements in a magnetically unshielded environment. This first requires that atomic magnetometers can operate in a finite magnetic field, and have enough high sensitivity. To meet these requirements, we develop a light-narrowed parametric resonance (LPR) magnetometer. By adding a modulation magnetic field to the large longitudinal magnetic field, our LPR magnetometer can measure small transverse magnetic fields with an intrinsic sensitivity of 3.5 fT/Hz1/2 in a longitudinal magnetic field of μT range. Moreover, we have also demonstrated that in contrast to the previous light-narrowed scalar magnetometers, our LPR magnetometer has the potential to achieve higher sensitivity. Because in our case spin-exchange relaxation suppression by using light narrowing can lead to an improvement of fundamental sensitivity limit regardless of which quantum noise is dominant, and hence the fundamental sensitivity is no longer limited by spin-exchange, and approaches the fundamental limit set by the spin-exchange and spin-destruction cross sections.

Clinical magnetocardiography: the unshielded bet-past, present, and future

Magnetocardiography (MCG), which is nowadays 60 years old, has not yet been fully accepted as a clinical tool. Nevertheless, a large body of research and several clinical trials have demonstrated its reliability in providing additional diagnostic electrophysiological information if compared with conventional non-invasive electrocardiographic methods. Since the beginning, one major objective difficulty has been the need to clean the weak cardiac magnetic signals from the much higher environmental noise, especially that of urban and hospital environments. The obvious solution to record the magnetocardiogram in highly performant magnetically shielded rooms has provided the ideal setup for decades of research demonstrating the diagnostic potential of this technology. However, only a few clinical institutions have had the resources to install and run routinely such highly expensive and technically demanding systems. Therefore, increasing attempts have been made to develop cheaper alternatives to improve the magnetic signal-to-noise ratio allowing MCG in unshielded hospital environments. In this article, the most relevant milestones in the MCG's journey are reviewed, addressing the possible reasons beyond the currently long-lasting difficulty to reach a clinical breakthrough and leveraging the authors' personal experience since the early 1980s attempting to finally bring MCG to the patient's bedside for many years thus far. Their nearly four decades of foundational experimental and clinical research between shielded and unshielded solutions are summarized and referenced, following the original vision that MCG had to be intended as an unrivaled method for contactless assessment of the cardiac electrophysiology and as an advanced method for non-invasive electroanatomical imaging, through multimodal integration with other non-fluoroscopic imaging techniques. Whereas all the above accounts for the past, with the available innovative sensors and more affordable active shielding technologies, the present demonstrates that several novel systems have been developed and tested in multicenter clinical trials adopting both shielded and unshielded MCG built-in hospital environments. The future of MCG will mostly be dependent on the results from the ongoing progress in novel sensor technology, which is relatively soon foreseen to provide multiple alternatives for the construction of more compact, affordable, portable, and even wearable devices for unshielded MCG inside hospital environments and perhaps also for ambulatory patients.